Chiesi Clinical Trial - Site 40503

Linz

0 studies enrolling now · 1 studies all time

What they study most

Chronic Obstructive Pulmonary Disease

Studies at this site

• A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) — Stopped early